Sensei Biotherapeutics Statistics
Total Valuation
SNSE has a market cap or net worth of $13.05 million. The enterprise value is -$34.19 million.
Important Dates
The next estimated earnings date is Tuesday, November 19, 2024, before market open.
| Earnings Date | Nov 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SNSE has 25.15 million shares outstanding. The number of shares has decreased by -18.11% in one year.
| Shares Outstanding | 25.15M |
| Shares Change (YoY) | -18.11% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 2.24% |
| Owned by Institutions (%) | 8.42% |
| Float | 16.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.25 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.90, with a Debt / Equity ratio of 0.10.
| Current Ratio | 10.90 |
| Quick Ratio | 10.57 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -278.41 |
Financial Efficiency
Return on equity (ROE) is -45.17% and return on invested capital (ROIC) is -28.09%.
| Return on Equity (ROE) | -45.17% |
| Return on Assets (ROA) | -27.03% |
| Return on Capital (ROIC) | -28.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.06M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.78% in the last 52 weeks. The beta is 0.06, so SNSE's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -24.78% |
| 50-Day Moving Average | 0.54 |
| 200-Day Moving Average | 0.80 |
| Relative Strength Index (RSI) | 48.76 |
| Average Volume (20 Days) | 823,199 |
Short Selling Information
The latest short interest is 223,158, so 0.89% of the outstanding shares have been sold short.
| Short Interest | 223,158 |
| Short Previous Month | 254,780 |
| Short % of Shares Out | 0.89% |
| Short % of Float | 1.35% |
| Short Ratio (days to cover) | 2.43 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -32.30M |
| Pretax Income | -29.67M |
| Net Income | -29.67M |
| EBITDA | -30.98M |
| EBIT | -32.30M |
| Earnings Per Share (EPS) | -$1.18 |
Full Income StatementBalance Sheet
The company has $52.29 million in cash and $5.05 million in debt, giving a net cash position of $47.24 million or $1.88 per share.
| Cash & Cash Equivalents | 52.29M |
| Total Debt | 5.05M |
| Net Cash | 47.24M |
| Net Cash Per Share | $1.88 |
| Equity (Book Value) | 52.19M |
| Book Value Per Share | 2.08 |
| Working Capital | 49.00M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$24.23 million and capital expenditures -$146,000, giving a free cash flow of -$24.38 million.
| Operating Cash Flow | -24.23M |
| Capital Expenditures | -146,000 |
| Free Cash Flow | -24.38M |
| FCF Per Share | -$0.97 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |